Michael Gulrajani
- Genetics top 2%
- Pathology and Forensic Medicine top 5%
- Hematology top 5%
- Molecular Biology
- Immunology
- Co-authors
- Todd CoveyAllard KapteinRaquel IzumiTjeerd BarfBas van de KarFanny KrantzBart van LithDennis Demont
- Topics
- Chronic Lymphocytic Leukemia Research (15 papers)Lymphoma Diagnosis and Treatment (9 papers)Chronic Myeloid Leukemia Treatments (3 papers)
- Journals
- BloodPLoS ONECancer Research
- Partner nations
- United StatesDenmarkSpain
In The Last Decade
Michael Gulrajani
17 papers receiving 651 citations
Peers
Comparison fields: 5 of 49
- Genetics 542
- Pathology and Forensic Medicine 408
- Hematology 206
- Molecular Biology 162
- Immunology 159
Countries citing papers authored by Michael Gulrajani
This map shows the geographic impact of Michael Gulrajani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gulrajani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gulrajani more than expected).
Fields of papers citing papers by Michael Gulrajani
This network shows the impact of papers produced by Michael Gulrajani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gulrajani. The network helps show where Michael Gulrajani may publish in the future.
Co-authorship network of co-authors of Michael Gulrajani
This figure shows the co-authorship network connecting the top 25 collaborators of Michael Gulrajani. A scholar is included among the top collaborators of Michael Gulrajani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Gulrajani. Michael Gulrajani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 57 | |
| 5 | 21 | |
| 6 | 7 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 71 | |
| 10 | 4 | |
| 11 | 272 | |
| 12 | 121 | |
| 13 | 43 | |
| 14 | 1 | |
| 15 | 36 | |
| 16 | 17 | |
| 17 | 6 | |
| 18 | 2 |
About Michael Gulrajani
Michael Gulrajani is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 18 papers that have together received 662 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (15 papers), Lymphoma Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Genetics (542 citations), Pathology and Forensic Medicine (408 citations) and Hematology (206 citations). Michael Gulrajani has collaborated with scholars based in United States, Denmark and Spain. Frequent co-authors include Todd Covey, Allard Kaptein, Raquel Izumi, Tjeerd Barf, Bas van de Kar, Fanny Krantz, Bart van Lith, Dennis Demont, Roger G. Ulrich and Diana Mittag. Their work appears in journals such as Blood, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.